Literature DB >> 23153855

Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?

Ludovic Samalin1, Sebastien Guillaume, Philippe Courtet, Mocrane Abbar, Sylvie Lancrenon, Pierre-Michel Llorca.   

Abstract

OBJECTIVE: Numerous guidelines for bipolar disorder have been published. The aim of this article is to underline the main differences between consensus-based guidelines (CBG) and evidence-based guidelines (EBG) currently available for the management of bipolar disorder.
METHODS: A literature search for guidelines published since 2006 was performed. A qualitative analysis was then conducted to compare the methodologies and the guidelines contents.
RESULTS: Comparison between CBG and EBG found more similarities than differences. However, discordances were found in the first-line choice of treatment (monotherapy or combination, use of lamotrigine or lithium in bipolar depression), time to reassessment and duration of maintenance treatment, introduction as from the acute phase a regimen compatible with long-term use and pharmacotherapy during pregnancy.
CONCLUSIONS: The choice of policy, whatever the methodology used, is up to the authors and can, therefore, depend on their interpretation of the available scientific evidence. Combining both methodologies (CBG and EBG) enables us to meet the complete definition of evidence-based medicine.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153855     DOI: 10.1016/j.comppsych.2012.10.001

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  5 in total

1.  Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.

Authors:  Pierre Michel Llorca; Mocrane Abbar; Philippe Courtet; Sebastien Guillaume; Sylvie Lancrenon; Ludovic Samalin
Journal:  BMC Psychiatry       Date:  2013-12-20       Impact factor: 3.630

Review 2.  Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.

Authors:  Richard A Epstein; Katherine M Moore; William V Bobo
Journal:  Drug Healthc Patient Saf       Date:  2014-12-24

3.  Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).

Authors:  Antoine Yrondi; Djamila Bennabi; Emmanuel Haffen; Marion Garnier; Frank Bellivier; Thierry Bourgerol; Vincent Camus; Thierry D'Amato; Olivier Doumy; Frédéric Haesebaert; Jérôme Holtzmann; Christophe Lançon; Philippe Vignaud; Fanny Moliere; Isabel Nieto; Raphaëlle Marie Richieri; Philippe Domenech; Corentin Rabu; Luc Mallet; Liova Yon; Laurent Schmitt; Florian Stephan; Guillaume Vaiva; Michel Walter; Pierre-Michel Llorca; Philippe Courtet; Marion Leboyer; Wissam El-Hage; Bruno Aouizerate
Journal:  Front Psychiatry       Date:  2017-11-24       Impact factor: 4.157

Review 4.  Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode.

Authors:  Dolores Keating; Stephen McWilliams; Ian Schneider; Caroline Hynes; Gráinne Cousins; Judith Strawbridge; Mary Clarke
Journal:  BMJ Open       Date:  2017-01-06       Impact factor: 2.692

5.  Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions.

Authors:  Ludovic Samalin; Eduard Vieta; Tarek Ahmed Okasha; Mm Jalal Uddin; Seyed Ali Ahmadi Abhari; Fethi Nacef; Vyacheslav Mishyiev; Dovi Aizenberg; Yaël Ratner; Lydie Melas-Melt; Idir Sedeki; Pierre Michel Llorca
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.